IP Library Granted Patent US 8,633,332
Granted Patent B2
US 8,633,332 · App. 13/379,008 · Granted Jan 21, 2014

Efficient isolation of cimiracemate A, and methods of use

Inventors: Lai Hung Cindy Yang (Hong Kong, CN); Allan Sy Lau (Hong Kong, CN)
Assignees: Purapharm Company Limited; Versitech Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,633,332
App. No.
13/379,008
Granted
Jan 21, 2014
Kind
B2
Abstract

A method for isolating cimiracemate A from a Cimicifuga species is disclosed, comprising the steps of a) providing a sufficient quantity of raw materials from the Cimicifuga species, b) mixing the raw materials from the Cimicifuga species with an aqueous polar solvent at a temperature of about 20° C. to about 28° C. to obtain a solvent extract comprising cimiracemate A, and c) isolating cimiracemate A from the solvent extract.

Claims (30)

1. A method for isolating cimiracemate A from a Cimicifuga species, comprising the steps of:

a) providing a sufficient quantity of raw material of a Cimicifuga species;

b) mixing the raw material of a Cimicifuga species with a solvent at a temperature of 20° C. to 28° C. to obtain a solvent extract comprising cimiracemate A, wherein the solvent is water-ethanol comprising ethanol at a concentration of less than 20%; and

c) isolating cimiracemate A from the solvent extract to yield a liquid or dried composition comprising cimiracemate A.

2. The method of claim 1 , wherein cimiracemate A is isolated from the solvent extract using high-performance liquid chromatography (HPLC).

3. The method of claim 2 , wherein cimiracemate A is eluted using HPLC from the solvent extract at UV absorbance of about 210 nm.

4. The method of claim 3 , wherein cimiracemate A is eluted using HPLC from the solvent extract at about 23° C.

5. The method of claim 1 , wherein the raw material of a Cimicifuga species is ground into powder.

6. The method of claim 1 , wherein the Cimicifuga species is selected from the group consisting of Cimicifuga racemosa, Cimicifuga foetida , and Cimicifuga heracleifolia.

7. The method of claim 6 , wherein the Cimicifuga species is Cimicifuga racemosa .

8. The method of claim 1 claim 1 , wherein the Cimicifuga species is mixed with water-ethanol at a ratio of about 1:15 to about 1:20 (w/v).

9. A method for isolating cimiracemate A from a Cimicifuga species, consisting of the steps of:

a) providing a sufficient quantity of raw material of a Cimicifuga species;

b) mixing the raw material of a Cimicifuga species with a solvent at a temperature of 20° C. to 28° C. to obtain a solvent extract comprising cimiracemate A, wherein the solvent is water or water-ethanol comprising ethanol at a concentration of less than 20%; and

c) isolating cimiracemate A from the solvent extract to yield a liquid composition comprising cimiracemate A.

10. The method of claim 9 , wherein the solvent is water.

11. The method of claim 10 , wherein the Cimicifuga species is mixed with water at a ratio of about 1:15 to about 1:20 (w/v).

12. A method for preparing a composition comprising the isolated cimiracemate A from claim 1 , further comprising formulating the isolated cimiracemate A into a composition selected from the group consisting of tablets, capsules, powders, pastilles, suppositories, oral solutions, suspensions, and injectable compositions.

13. The method of claim 12 , comprising formulating the isolated cimiracemate A into a composition selected from the group consisting of tablets, capsules, powder, and pastilles.

14. A method for isolating cimiracemate A from a Cimicifuga species, comprising the steps of:

a) providing a sufficient quantity of raw material of a Cimicifuga species;

b) mixing the raw material of a Cimicifuga species with water as the solvent at a temperature of 20° C. to 28° C. to obtain a water extract comprising cimiracemate A; and

c) isolating cimiracemate A from the water extract to yield a liquid or dried composition comprising cimiracemate A.

15. The method of claim 14 , wherein the raw material of a Cimicifuga species is ground into powder.

16. The method of claim 14 , wherein the Cimicifuga species is selected from the group consisting of Cimicifuga racemosa, Cimicifuga foetida , and Cimicifuga heracleifolia.

17. The method of claim 16 , wherein the Cimicifuga species is Cimicifuga racemosa.

18. The method of claim 14 , wherein the Cimicifuga species is mixed with water at a ratio of about 1:15 to about 1:20 (w/v).

19. The method of claim 17 , wherein Cimicifuga racemosa is mixed with water at a ratio of about 1:15 (w/v).

20. A method for preparing a composition comprising the isolated cimiracemate A from claim 14 , further comprising formulating the isolated cimiracemate A into a composition selected from the group consisting of tablets, capsules, powders, pastilles, suppositories, oral solutions, suspensions, and injectable compositions.

21. The method of claim 20 , comprising formulating the isolated cimiracemate A into a composition selected from the group consisting of tablets, capsules, powder, and pastilles.

Assignments (3)
CHANGE OF NAME Recorded Nov 13, 2015
From: PURAPHARM COMPANY LIMITED
To: BAGI RESEARCH LIMITED
Reel/Frame 037034/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2013
From: PURAPHARM INTERNATIONAL (H.K.) LIMITED; VERSITECH LIMITED
To: PURAPHARM COMPANY LIMITED; VERSITECH LIMITED
Reel/Frame 029553/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: YANG, LAI HUNG CINDY; LAU, ALLAN SY
To: PURAPHARM INTERNATIONAL (HK) LIMITED; VERSITECH LIMITED
Reel/Frame 029038/0171 →
Continuity (2)
Provisional Application 61218962 · Jun 21, 2009
Related Publication 20120190882A1 · Jul 26, 2012